SEC FORM 4
$2,020,022.82
Travere Therapeutics, Inc. (TVTX)
Sale of 37,270 shares at $54.1997 per share.
Reporting Person Dube Eric M · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001763494-26-000008 · filed 2026-10-19 · View filing →